Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keisuke Mori
Observed name:
*Keisuke Mori
Institutions:
Jikei University School of Medicine,
National Center of Neurology and Psychiatry,
National Institute of Mental Health
Observed institutions:
Jikei University School of Medicine,
National Center of Neurology and Psychiatry,
National Institute of Mental Health
ORCID:
0000-0003-0731-5104
Observed ORCID:
0000-0003-0731-5104
OpenAlex ID:
A5101875475
Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
2023
·
Keisuke Mori
, Fumitoshi Kodaka
, et al.
·
Neuropsychopharmacology Reports
·
2
PDF
Association of Self‐Reported Clinical Behavior With Guideline Adherence in Schizophrenia and Major Depressive Disorder After Guideline Education
2026
·
Kazuhiko Yamamuro
, Hikaru Hori
, et al.
·
Neuropsychopharmacology Reports
PDF
Drug cost structure of psychotropic medications in schizophrenia and major depressive disorder: A multicenter study in Japan
2026
·
Shinichiro Ochi
, Yusuke Arai
, et al.
·
Asian Journal of Psychiatry
guideline adherence rate for schizophrenia and major depressive disorder as a measure of educational impact in psychiatric guideline implementation: A multicenter study
2026
·
Toru Horinouchi
, Yusuke Arai
, et al.
·
Asian Journal of Psychiatry
Prevalence of Treatment‐Resistant Schizophrenia: A Nationwide Multicenter Study
2026
·
Yusuke Arai
, Toru Horinouchi
, et al.
·
Neuropsychopharmacology Reports
PDF
Nationwide expansion of the EGUIDE project in Japan: A nine‐year overview
2026
·
Hiroyuki Muraoka
, Keisuke Mori
, et al.
·
Psychiatry and Clinical Neurosciences Reports
Association Between Participant Satisfaction and Self‐Reported Clinical Practice Behaviors in a Nationwide Guideline Education Program
2026
·
Kazuhiko Yamamuro
, Kenta Ide
, et al.
·
Neuropsychopharmacology Reports
The introduction of measurement-based care for patients with schizophrenia may improve psychiatric symptoms and guideline adherence rate
2026
·
Keisuke Mori
, Junya Matsumoto
, et al.
·
The International Journal of Neuropsychopharmacology
Association Between Plasma SITH‐1 Antibody Titers and Treatment Trajectory of Treatment‐Resistant Depression
2025
·
Keisuke Mori
, Fumitoshi Kodaka
, et al.
·
Neuropsychopharmacology Reports
PDF
“Discrepancy between subjective and objective assessments focusing on item-level symptom improvement in repetitive transcranial magnetic stimulation therapy for treatment-resistant depression: A two-site prospective study”
2025
·
Shun Igarashi
, Yuki Matsuda
, et al.
·
Psychiatry Research
Characteristics of Pharmacotherapy During Pregnancy and Non-pregnancy in Patients With Psychiatric Disorders: a Preliminary Comparison
2025
·
*Tamayo Kobayashi
, Fumitoshi Kodaka
, et al.
·
The International Journal of Neuropsychopharmacology
Characteristics of Antidepressant Classes for Treatment- Resistant Depression as Defined by the Number of Valid Pharmacotherapies
2025
·
*Keisuke Mori
, Fumitoshi Kodaka
, et al.
·
The International Journal of Neuropsychopharmacology
Factors Associated With Longitudinal Decrease in Doses of Benzodiazepine Hypnotics in Patients With Depressive Disorders
2025
·
*Yoshiyuki Sakai
, Junpei Ishii
, et al.
·
The International Journal of Neuropsychopharmacology
PDF
Show more works
View as search
Works count:
13
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type